Medicare Innovation Responsiveness Act of 2003

H.R.941/S.823-Medicare Innovation Responsiveness Act of 2003 H.R.569-Medicare Patient Access to Preventive and Diagnostic Tests Act of 2003 H.R.180-Medicare Regulatory and Contracting Reform Act of 2003 H.R.2373/H.R.1-Medicare Prescription Drug and Modernization Act of 2003 S.1-Prescription Drug and Medicare Improvement Act of 2003 S.1054-Jobs and Growth Tax Relief Reconciliation Act of 2003 (Bills under the Medicare program to provide for the expeditious coverage of new medical technology; establish procedures for determining payment amounts for new clinical diagnostic laboratory tests for which payment is made; to strengthen and improve and modernize the Medicare program; and to provide regulatory relief and contracting flexibility.) H.R.883-Medicare Laboratory Services Access Act of 2003 (Bill to adjust the fee for collecting speciments for clinical diagnostic laboratory tests under the Medicare program.) H.R.2342/S.1179-Medicare Chronic Care Improvement Act of 2003 H.R.5219-Essential Medicines for Medicare Act of 2002 (Bills to expand Medicare benefits to prevent, delay, and minimize the progression of chronic conditions, and develop national policies on effective chronic condition care.)

Client expense: $2,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), SENATE

S. 1, H.R. 1 H.RES. 299, H.R. 359, H.R. 2473, H.R. 2596: “Medicare Prescription Drug and Modernization Act of 2003” Legislation to amend title XVIII of the Social Security Act to provide for a voluntary program for prescription drug coverage under the Medicare Program, to modernize the Medicare Program, to amend the Internal Revenue Code of 1986 to allow a deduction to individuals for amounts contributed to health savings security accounts and health savings accounts, to provide for the disposition of unused health benefits in cafeteria plans and flexible spending arrangements, and for other purposes. S. 7 “Prescription Drug Benefit and Cost Containment Act of 2003” Legislation to amend title XVIII of the Social Security Act to provide coverage of outpatient prescription drugs under the Medicare program and to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals, and for other purposes. S. 382: “Medicare Cholesterol Screening Coverage Act of 2003” Legislation to amend title XVIII of the Social Security Act to provide for coverage of cardiovascular screening tests under the Medicare program. S. 823, H.R. 941: “Medicare Innovation Responsiveness Act of 2003” Legislation to amend title XVIII of the Social Security Act to provide for the expeditious coverage of new medical technology under the Medicare program, and for other purposes. H.R. 810: “Medicare Regulatory and Contracting Reform Act of 2003” Legislation to amend title XVIII of the Social Security Act to provide regulatory relief and contracting flexibility under the Medicare Program. H.R. 1568: “Medicare Rx Now Act of 2003” Legislation to amend part B of title XVIII of the Social Security Act to provide for a prescription drug benefit with a high deductible at no additional premium and access to discount prices on drugs and to provide for the operation of such benefit without a deductible for certain low-income Medicare beneficiaries. H.J.RES.3 Legislation to disapprove under the Congressional Review Act the rule submitted by the Centers for Medicare & Medicaid Services, relating to revisions to payment policies under the Medicare physician fee schedule for calendar year 2003 and other items, published in the Federal Register on December 31, 2002. Department of Health and Human Services, Centers for Medicare and Medicaid Services, 42 CFR Parts 412 and 413, Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2004 Rates; Proposed Rule, May 19, 2003 Communications with Centers for Medicare and Medicaid Services, U.S. Congress and Administration requesting National Coverage Decision for MADIT II indication for ICDs and provided supporting information.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)